The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adaptimmune Therapeutics plc Sponsored ADR 00653A107   4,041,058 5,095,912 SH   SOLE   5,095,912 0 0
ALX Oncology Holdings Inc. Common 00166B105   18,832,262 1,264,759 SH   SOLE   1,264,759 0 0
Amicus Therapeutics Inc. Common 03152W109   10,158,380 715,883 SH   SOLE   715,883 0 0
Avadel Pharmaceuticals PLC Sponsored ADR 05337M104   9,389,602 664,986 SH   SOLE   664,986 0 0
Axsome Therapeutics, Inc. Common 05464T104   7,432,671 93,387 SH   SOLE   93,387 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107   17,015,566 478,234 SH   SOLE   478,234 0 0
Cullinan Oncology, Inc. Common 230031106   77,935,851 7,648,268 SH   SOLE   7,648,268 0 0
CYMABAY THERAPEUTICS INC Common 23257D103   14,436,095 611,181 SH   SOLE   611,181 0 0
Disc Medicine Inc Common 254604101   2,888,000 50,000 SH   SOLE   50,000 0 0
Geron Corporation Common 374163103   22,609,958 10,715,620 SH   SOLE   10,715,620 0 0
Harpoon Therapeutics, Inc. Common 41358P205   3,634,648 319,670 SH   SOLE   319,670 0 0
Inozyme Pharma Inc. Common 45790W108   1,379,443 323,813 SH   SOLE   323,813 0 0
Insmed Incorporated Common 457669307   16,367,369 528,150 SH   SOLE   528,150 0 0
Intellia Therapeutics, Inc. Common 45826J105   11,665,413 382,598 SH   SOLE   382,598 0 0
Iovance Biotherapeutics Inc Common 462260100   26,743,391 3,289,470 SH   SOLE   3,289,470 0 0
Karuna Therapeutics Inc Common 48576A100   16,863,336 53,279 SH   SOLE   53,279 0 0
iTeos Therapeutics, Inc. Common 46565G104   19,118,076 1,745,943 SH   SOLE   1,745,943 0 0
Madrigal Pharmaceuticals inc Common 558868105   9,465,756 40,910 SH   SOLE   40,910 0 0
Moonlake Immunotherapeutics Class A Ord. 61559X104   17,789,445 294,576 SH   SOLE   294,576 0 0
MORPHIC HOLDING INC Common 61775R105   9,349,669 323,742 SH   SOLE   323,742 0 0
Olema Pharmaceuticals, Inc. Common 68062P106   26,055,618 1,857,136 SH   SOLE   1,857,136 0 0
Phathom Pharmaceuticals inc Common 71722W107   639,100 70,000 SH   SOLE   70,000 0 0
REGENXBIO Inc. Common 75901B107   9,855,950 549,078 SH   SOLE   549,078 0 0
Relay Therapeutics Inc. Common 75943R102   9,160,507 832,017 SH   SOLE   832,017 0 0
Repare Therapeutics, Inc. Common 760273102   11,970,898 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100   7,841,341 273,408 SH   SOLE   273,408 0 0
Structure Therapeutics Inc. Sponsored ADS 86366E106   9,403,169 230,696 SH   SOLE   230,696 0 0
Verve Therapeutics, Inc Common 92539P101   8,895,992 638,163 SH   SOLE   638,163 0 0
VIKING THERAPEUTICS INC Common 92686J106   6,053,535 325,284 SH   SOLE   325,284 0 0
Viridian Therapeutics Inc Common 92790C104   2,178,000 100,000 SH   SOLE   100,000 0 0
Xeris Biopharma Holdings Inc Common 98422E103   9,040,995 3,847,232 SH   SOLE   3,847,232 0 0
Werewolf Therapeutics, Inc. Common 95075A107   9,217,722 2,388,011 SH   SOLE   2,388,011 0 0